Initial national priorities for comparative effectiveness research

Initial National Priorities for Comparative Effectiveness Research

Volumn , Issue , 2009, Pages 1-227

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85024092590     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.17226/12648     Document Type: Book

References (204)

1. IOM (Institute of Medicine). 1990a. Acute myocardial infarction: Setting priorities for effectiveness research. Edited by P. H. Mattingly and K. N. Lohr. Washington, DC: National Academy Press.
2. IOM 1990b. Breast cancer: Setting priorities for effectiveness research. Washington, DC: National Academy Press.
3. IOM 1990c. Clinical practice guidelines: Directions for a new program. Edited by M. J. Field and K. N. Lohr. Washington, DC: National Academy Press.
4. IOM 1990d. Consensus development at the NIH: Improving the program Washington, DC: National Academy Press.
5. IOM 1990e. Hip fracture: Setting priorities for effectiveness research. Edited by K. A. Heithoff and L. K. N. Washington, DC: National Academy Press.
6. IOM 1992. Setting Priorities for Health Technology Assessment: A Model Process. Edited by M. S. Donaldson and H. C. Sox. Washington, DC: National Academy Press.
7. IOM 1995. Setting priorities for clinical practice guidelines. Edited by M. J. Field. Washington, DC: National Academy Press.
8. IOM 1998. Scientific opportunities and public needs: Improving priority setting and public input at the National Institutes of Health. Washington, DC: National Academy Press.
9. IOM 2003. Priority areas for national action: Transforming health care quality. Edited by K. Adams and J. Corrigan, Quality chasm series; Variation: Quality chasm series. Washington, DC: The National Academies Press.
10. IOM 2007a. The Learning healthcare system: Workshop summary. The IOM Roundtable on Evidence-Based Medicine. Edited by L. Olsen, D. Aisner, and J. M. McGinnis. Washington, DC: The National Academies Press.
11. IOM 2007b. Learning what works best: The nation's need for evidence on comparative effectiveness in health care. http://www.iom.edu/ebm-effectiveness (accessed April 15, 2009).
12. IOM 2008. Knowing what works in health care: A roadmap for the nation. Edited by J. Eden, B. Wheatley, B. J. McNeil, and H. Sox. Washington, DC: The National Academies Press.
13. AHRQ (Agency for Healthcare Research and Quality). 2009a. AHRQ Effective Health Care glossary http://effectivehealthcare.ahrq.gov/tools.cfm?tooltype=glossary&TermID=118 (accessed April 4, 2009).
14. AHRQ 2009b. Centers for Education & Research on Therapeutics (CERTs) http://www.certs. hhs.gov/ (accessed April 9, 2009).
15. American College of Physicians. 2008. Improved availability of comparative effectiveness information: An essential feature for a high-quality and efficient United States health care system. Philadelphia, PA.
16. Avorn, J. 2009. Debate about funding comparative-effectiveness research. New England Journal of Medicine 360(19):1927-1929.
17. Birkmeyer, N. J. O., J. N. Weinstein, A. N. A. Tosteson, T. D. Tosteson, J. S. Skinner, J. D. Lurie, R. Deyo, and J. E. Wennberg. 2002. Design of the spine patient outcomes research trial (SPORT). Spine 27(12):1361-1372.
18. Blue Cross and Blue Shield Association. 2009. Technology Evaluation Center criteria http:// www.bcbs.com/blueresources/tec/tec-criteria.html (accessed May 1, 2009).
19. Bravata, D. M., A. L. Gienger, K. M. McDonald, V. Sundaram, M. V. Perez, R. Varghese, J. R. Kapoor, R. Ardehali, D. K. Owens, and M. A. Hlatky. 2007. Systematic review: The comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery. Annals of Internal Medicine 147(10):703-716.
20. CBO (Congressional Budget Office). 2008. Technological change and the growth of health care spending. In CBO paper. Place Published: United States Congressional Budget Office. http://www.cbo.gov/ftpdocs/89xx/doc8947/01-31-TechHealth.pdf (accessed April 30, 2008).
21. CDC (Centers for Disease Control and Prevention). 2007. Morbidity and mortality weekly report. 56:880-888.
22. Chou, R., R. Fu, S. Carson, S. Saha, and M. Helfand. 2007. Methodological shortcomings predicted lower harm estimates in one of two sets of studies of clinical interventions. Journal of Clinical epidemiology 60(1):18-28.
23. CMS (Centers for Medicare & Medicaid Services). 2009a. Mission, vision and goals overview http://www.cms.hhs.gov/MissionVisionGoals/ (accessed May 22, 2009).
24. CMS 2009b. National health expenditures aggregate, per capita amounts, percent distribution, and average annual percent growth, by source of funds: Selected calendar years 1960-2007 http://www.cms.hhs.gov/NationalHealthExpendData/downloads/tables.pdf (accessed May 1, 2009).
25. CMTP (Center for Medical Technology Policy). 2009. Welcome to the Center for Medical Technology Policy http://www.cmtpnet.org/ (accessed April 9, 2009).
26. Cochrane, A. L. 1971. Effectiveness and efficiency: Random reflections on health services. London: Nuffield Provincial Hospitals Trust.
27. Cochrane Collaboration. 2001. Cochrane Collaboration consumer network http://www. cochraneconsumer.com/ (accessed April 28, 2009).
28. Cochrane Collaboration. 2005. Glossary of terms in the Cochrane Collaboration. Version 4.2.5. www.cochrane.org (accessed November 27, 2006).
29. Cochrane Collaboration. 2009. Product descriptions-record counts http://www.interscience.wiley.com/egibin/mrwhome/106568753/ProductDescriptions.html (accessed April 24, 2009).
30. Duckworth, W., C. Abraira, T. Moritz, D. Reda, N. Emanuele, P. D. Reaven, F. J. Zieve, J. Marks, S. N. Davis, R. Hayward, S. R. Warren, S. Goldman, M. McCarren, M. E. Vitek, W. G. Henderson, and G. D. Huang. 2009. Glucose control and vascular complications in veterans with type 2 diabetes. New England Journal of Medicine 360(2):129-139.
31. ECRI Institute. 2009. Pioneering applied scientific research in healthcare https://www.ecri.org/about/pages/default.aspx (accessed April 24, 2009).
32. Epstein, S. 1996. Impure science: AIDS, activism, and the politics of knowledge. In Medicine and society. Place Published: University of California Press. http://www.loc.gov/catdir/bios/ucal051/96016805.html (accessed April 21, 2009).
33. Findlay, S. D. 2006. Bringing the DERP to consumers: 'Consumer Reports Best Buy drugs'. Health Affairs 25(4):w283-w286.
34. Fisher, E. S., D. E. Wennberg, T. A. Stukel, D. J. Gottlieb, F. L. Lucas, and E. L. Pinder. 2003. The implications of regional variations in Medicare spending. Part 2: Health outcomes and satisfaction with care. Annals of Internal Medicine 138(4):288-298.
35. Fisher, E. S., J. P. Bynum, and J. S. Skinner. 2009. Slowing the growth of health care costs- Lessons from regional variation. New England Journal of Medicine 360(9):849-852.
36. GAO (Government Accountability Office). 2002. Medicare: Beneficiary use of clinical preventive services. Report to the Chairman, Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives. Washington, DC.
37. Garber, A. M., and D. O. Meltzer. 2009. Setting priorities for comparative effectiveness research. Paper presented at Implementing Comparative Effectiveness Research: Priorities, Methods, and Impact, Engleberg Center for Health Care Reform at Brookings: Washington, DC.
38. Garber, A. M., and S. R. Tunis. 2009. Does comparative-effectiveness research threaten personalized medicine? New England Journal of Medicine 360(19):1925-1927.
39. Glickman, S. W., F. S. Ou, E. R. DeLong, M. T. Roe, B. L. Lytle, J. Mulgund, J. S. Rumsfeld, W. B. Gibler, E. M. Ohman, K. A. Schulman, and E. D. Peterson. 2007. Pay for performance, quality of care, and outcomes in acute myocardial infarction. JAMA 297(21):2373-2380.
40. Gottlieb, S. 2009. Congress wants to restrict drug access: A bill in the House could tie your doctor's hands. Wall Street Journal, January 20, 2009.
41. Harpole, L. H., M. J. Kelley, G. Schreiber, E. M. Toloza, J. Kolimaga, and D. C. McCrory. 2003. Assessment of the scope and quality of clinical practice guidelines in lung cancer. Chest 123(1 SUPPL.):7S-20S.
42. Hayes Inc. 2009. Hayes: Transforming healthcare with evidence http://www.hayesinc.com/hayes/ (accessed May 8, 2009).
43. Haynes, R. B., D. L. Sackett, G. H. Guyatt, and P. Tugwell. 2006. Clinical epidemiology: How to do clinical practice research. 3rd ed. Philadelphia, PA: Lipincott Williams & Wilkins.
44. Helfand, M. 2005. Using evidence reports: Progress and challenges in evidence-based decision making. Health Affairs 24(1):123-127.
45. Higgins, J., and S. Green. 2008. Cochrane handbook for systematic re-views of interventions: Version 5.0.1 Place Published: The Cochrane Collaboration, 2008. http://www.cochrane.org/resources/handbook/index.htm (accessed April 2, 2009).
46. Hlatky, M. A., D. B. Boothroyd, D. M. Bravata, E. Boersma, J. Booth, M. M. Brooks, D. Carrie, T. C. Clayton, N. Danchin, M. Flather, C. W. Hamm, W. A. Hueb, J. Kahler, S. F. Kelsey, S. B. King, A. S. Kosinski, N. Lopes, K. M. McDonald, A. Rodriguez, P. Serruys, U. Sigwart, R. H. Stables, D. K. Owens, and S. J. Pocock. 2009. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: A collaborative analysis of individual patient data from ten randomised trials. The Lancet 373(9670):1190-1197.
47. Holve, E., S. Mercer, J. Kupersmith, and S. Phurrough. 2008. Exploring comparative effectiveness: Activities of CDC, VA and CMS to advance evidenced-based health. National Health Policy Forum The George Washington University, http://www.nhpf.org/library/details.cfm/2646 (accessed October 3, 2008).
48. Hueb, W., N. H. Lopes, B. J. Gersh, P. Soares, L. A. C. Machado, F. B. Jatene, S. A. Oliveira, and J. A. F. Ramires. 2007. Five-year follow-up of the medicine, angioplasty, or surgery study (MASS II): A randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation 115(9):1082-1089.
49. Institute for Clinical and Economic Review. 2009. Mission. http://www.icer-review.org/index.php/about.html (accessed April 9, 2009).
50. IOM (Institute of Medicine). 2001. Crossing the quality chasm: A new health system for the 21st century, Edited by J. M. Corrigan. Washington, DC: National Academy Press. http://www.nap.edu/catalog/10027.html (accessed April 20, 2009).
51. IOM 2007. Learning what works best: The nation's need for evidence on comparative effectiveness in health care. http://www.iom.edu/ebm-effectiveness (accessed April 15, 2009).
52. IOM 2008. Knowing what works in health care: A roadmap for the nation. Edited by J. Eden, B. Wheatley, B. J. McNeil and H. Sox. Washington, DC: The National Academies Press.
53. Ischemic Optic Neuropathy Decompression Trial Research Group. 1995. Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. JAMA 273(8):625-632.
54. Jha, A. K., J. B. Perlin, K. W. Kizer, and R. A. Dudley. 2003. Effect of the transformation of the Veterans Affairs health care system on the quality of care. New England Journal of Medicine 348(22):2218-2227.
55. Johnston, S. C., and S. L. Hauser. 2009. Comparative effectiveness research in the neurosciences. Annals of Neurology 65(2):A6-A8.
56. Kurian, A. W., R. N. Thompson, A. F. Gaw, S. Arai, R. Ortiz, and A. M. Garber. 2007. A cost-effectiveness analysis of adjuvant trastuzumab regimens in early HER2/neu-positive breast cancer. Journal of Clinical Oncology 25(6):634-641.
57. Last, J. M. 2001. A dictionary of epidemiology. New York: Oxford University Press.
58. Lauer, M. S. 2009. Comparative effectiveness research: The view from the NHLBI. Journal of the American College of Cardiology 53(12):1084-1086.
59. Lohr, K. N. 2007. Emerging methods in comparative effectiveness and safety: Symposium overview and summary. Medical Care 45(10 SUPPL. 2):S5-S8.
60. Mangione-Smith, R., A. H. DeCristofaro, C. M. Setodji, J. Keesey, D. J. Klein, J. L. Adams, M. A. Schuster, and E. A. McGlynn. 2007. The quality of ambulatory care delivered to children in the United States. New England Journal of Medicine 357(15):1515-1523.
61. McGlynn, E. A., S. M. Asch, J. Adams, J. Keesey, J. Hicks, A. DeCristofaro, and E. A. Kerr. 2003. The quality of health care delivered to adults in the United States. New England Journal of Medicine 348(26):2635-2645.
62. Medicare Payment Advisory Commission. 2008. Report to the Congress: Reforming the delivery system. Washington, DC.
63. NCI (National Cancer Institute). 2006. NCI's clinical trials cooperative group program http://cancertrials.nci.nih.gov/cancertopics/factsheet/nci/clinical-trials-cooperative-group (accessed June 15, 2009).
64. NIH PGRN (National Institutes of Health Pharmacogenetics Research Network). 2009. PGRN mission statement http://www.pharmgkb.org/network/pgrn_mission_statement.jsp (accessed June 12, 2009).
65. Oregon Health and Science University. 2009. Drug Effectiveness Review Project http://www.ohsu.edu/drugeffectiveness/ (accessed April 8, 2009).
66. Orszag, P. R. 2007. Research on the comparative effectiveness of medical treatments: Options for an expanded federal role: CBO testimony before the Subcommittee on Health, Committee on Ways and Means, U.S. House of Representatives. U.S. Congressional Budget Office. http://www.cbo.gov/ftpdocs/82xx/doc8209/Comparative%5FTestimony.pdf (accessed April 28, 2009).
67. Oxman, M. N., M. J. Levin, G. R. Johnson, K. E. Schmader, S. E. Straus, L. D. Gelb, R. D. Arbeit, M. S. Simberkoff, A. A. Gershon, L. E. Davis, A. Weinberg, K. D. Boardman, H. M. Williams, J. H. Zhang, P. N. Peduzzi, C. E. Beisel, V. A. Morrison, J. C. Guatelli, P. A. Brooks, C. A. Kauffman, C. T. Pachucki, K. M. Neuzil, R. F. Betts, P. F. Wright, M. R. Griffin, P. Brunell, N. E. Soto, A. R. Marques, S. K. Keay, R. P. Goodman, D. J. Cotton, J. W. Gnann Jr, J. Loutit, M. Holodniy, W. A. Keitel, G. E. Crawford, S. S. Yeh, Z. Lobo, J. F. Toney, R. N. Greenberg, P. M. Keller, R. Harbecke, A. R. Hayward, M. R. Irwin, T. C. Kyriakides, C. Y. Chan, I. S. F. Chan, W. W. B. Wang, P. W. Annunziato, and J. L. Silber. 2005. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. New England Journal of Medicine 352(22):2271-2284+2365.
68. Plevritis, S. K., A. W. Kurian, B. M. Sigal, B. L. Daniel, D. M. Ikeda, F. E. Stockdale, and A. M. Garber. 2006. Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging. JAMA 295(20):2374-2384.
69. Santaguida, P. L., M. Helfand, and P. Raina. 2005. Challenges in systematic reviews that evaluate drug efficacy or effectiveness. Annals of Internal Medicine 142(12_Part_2):1066-1072.
70. Sisko, A., C. Truffer, S. Smith, S. Keehan, J. Cylus, J. A. Poisal, M. K. Clemens, and J. Lizonitz. 2009. Health spending projections through 2018: Recession effects add uncertainty to the outlook. Health Affairs 28(2):w346-357.
71. Slutsky, J. R., and C. M. Clancy. 2009. AHRQ's Effective Health Care Program: Why comparative effectiveness matters. American Journal of Medical Quality 24(1):67-70.
72. Sparano, J. A., M. Wang, S. Martino, V. Jones, E. A. Perez, T. Saphner, A. C. Wolff, G. W. Sledge, Jr., W. C. Wood, and N. E. Davidson. 2008. Weekly paclitaxel in the adjuvant treatment of breast cancer. New England Journal of Medicine 358(16):1663-1671.
73. Tosteson, A. N. A., J. D. Lurie, T. D. Tosteson, J. S. Skinner, H. Herkowitz, T. Albert, S. D. Boden, K. Bridwell, M. Longley, G. B. Andersson, E. A. Blood, M. R. Grove, and J. N. Weinstein for the SPORT Investigators. 2008. Surgical treatment of spinal stenosis with and without degenerative spondylolisthesis: Cost-effectiveness after 2 years. Annals of Internal Medicine 149(12):845-853.
74. Tricoci, P., J. M. Allen, J. M. Kramer, R. M. Califf, and S. C. Smith, Jr. 2009. Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA 301(8):831-841.
75. Tunis, S. R., and S. D. Pearson. 2006. Coverage options for promising technologies: Medicare's 'coverage with evidence development.' Health Affairs 25(5):1218-1230.
76. Tunis, S. R., D. B. Stryer, and C. M. Clancy. 2003. Practical clinical trials: Increasing the value of clinical research for decision making in clinical and health policy. JAMA 290(12):1624-1632.
77. VA (Veterans Affairs). 2009. Evidenced-based synthesis program http://www.hsrd.research.va.gov/publications/esp/ (accessed May 22, 2009).
78. Veteran's Health Administration. 2009. Cooperative studies program (CSP) http://www.research.va.gov/programs/csrd/csp.cfm (accessed May 1, 2009).
79. Vigna-Taglianti, F., P. Vineis, A. Liberati, and F. Faggiano. 2006. Quality of systematic reviews used in guidelines for oncology practice. Annals of Oncology 17(4):691-701.
80. Weinstein, J. N., T. D. Tosteson, J. D. Lurie, A. N. A. Tosteson, E. Blood, B. Hanscom, H. Herkowitz, F. Cammisa, T. Albert, S. D. Boden, A. Hilibrand, H. Goldberg, S. Berven, H. An, and the SPORT Investigators. 2008. Surgical versus nonsurgical therapy for lumbar spinal stenosis. New England Journal of Medicine 358(8):794-810.
81. Wennberg, J. E., A. M. O'Connor, E. D. Collins, and J. N. Weinstein. 2007. Extending The P4P agenda, part 1: How Medicare can improve patient decision making and reduce unnecessary care. Health Affairs 26(6):1564-1574.
82. West, S., V. King, T. Carey, K. Lohr, N. McCoy, S. Sutton, and L. Lux. 2002. Systems to rate the strength of scientific evidence. Evidence Report/Technology Assessment No. 47. (Prepared by the Research Triangle Institute-University of North Carolina Evidence-based Practice Center under Contract No. 290-97-0011). AHRQ Publication No. 02-E016. Rockville, MD: Agency for Healthcare Research and Quality.
83. Whitlock, E. P., S. A. Lopez, S. Chang, M. Helfand, M. Eder, and N. Floyd. 2009. Identifying, selecting, and refining topics for comparative effectiveness systematic reviews: AHRQ and the effective health care program. http://effectivehealthcare.ahrq.gov/repFiles/ 20090427IdenttifyingTopics.pdf (accessed June 5, 2009).
84. Fauci, A. S., E. Braunwald, D. L. Kasper, S. L. Hauser, D. L. Longo, J. L. Jameson, and J. Loscalzo. 2008. Harrison's principles of internal medicine, 17th edition Place Published: McGraw-Hill Companies. http://www.accessmedicine.com/resourceTOC.aspxPresourceID=4 (accessed May 21, 2009).
85. AHRQ (Agency for Healthcare Research and Quality). 2009. Medical Expenditure Panel Survey. http://www.meps.ahrq.gov/mepsweb/ (accessed March 10, 2009).
86. Doyle, J., E. Waters, D. Yach, D. McQueen, A. De Francisco, T. Stewart, P. Reddy, A. M. Gulmezoglu, G. Galea, and A. Portela. 2005. Global priority setting for Cochrane systematic reviews of health promotion and public health research. Journal of Epidemiology and Community Health 59:193-197.
87. FAACT. 1997. The FACCT consumer information framework: Comparative information for better health care decisions http://www.facct.org/information.html (no longer accessible).
88. HHS (Department of Health and Human Services). 2000. Healthy People 2010: Understanding and improving health. U.S. Government Printing Office. http://purl.access.gpo.gov/ GPO/LPS4217 (accessed April 3, 2009). THE CRITERIA AND PROCESS FOR SETTING PRIORITIES 95
89. HHS 2008. Recommendations for the framework and format of Healthy People 2020. http://www.healthypeople.gov/HP2020/advisory/PhaseI/sec5.htm#_Toc211942927 (accessed June 12, 2009).
90. IOM (Institute of Medicine). 2003. Priority areas for national action: Transforming health care quality. Edited by K. Adams and J. Corrigan. Washington, DC: The National Academies Press.
91. IOM 2008. Knowing what works in health care: A roadmap for the nation. Edited by J. Eden, B. Wheatley, B. J. McNeil and H. Sox. Washington, DC: The National Academies Press.
92. Kung, H.-C., D. L. Hoyert, J. Xu, S. L. Murphy, and Division of Vital Statistics. 2008. Deaths: Final data for 2005. National vital statistics re-ports National Center for Health Statistics.
93. Markle Foundation. 2008. FACCT legacy documents http://www.markle.org/archives/facct/ (accessed May 12, 2009).
94. NPP (National Priorities Partnership). 2008. National priorities and goals. Washington, DC: National Quality Forum.
95. Oxman, A., H. Schunemann, and A. Fretheim. 2006. Improving the use of research evidence in guideline development: 2. Priority setting. Health Research Policy and Systems 4(1):14.
96. Wennberg, J. E. 2009 (unpublished). Recommendations to the Institute of Medicine on comparative effectiveness research priorities. Submitted in response to a request from the Institute of Medicine Committee on Comparative Effectiveness Research Prioritization. The Dartmouth Institute for Health Policy and Clinical Practice.
97. Whitlock, E. P., S. A. Lopez, S. Chang, M. Helfand, M. Eder, and N. Floyd. 2009. Identifying, selecting, and refining topics for comparative effectiveness systematic reviews: AHRQ and the effective health care program. http://effectivehealthcare.ahrq.gov/repFiles/ 20090427IdenttifyingTopics.pdf (accessed June 5, 2009).
98. AHRQ (Agency for Healthcare Research and Quality). 2009a. Medical Expenditure Panel Survey. Total expenses for conditions by site of service: United States http://www.meps.ahrq.gov/mepsweb/ (accessed March 10, 2009).
99. AHRQ 2009b. Total number of events accounting for expenditures by site of service: United States, 2006. In Medical Expenditure Panel Survey Component Data.
100. AHRQ 2009c. Total number of people accounting for expenditures (deduplicated) by site of service: United States, 2006. In Medical Expenditure Panel Survey Component Data. AHRQ Effective Health Care Program. 2009. Effective Health Care: Topic triage cover sheets.
101. Doyle, J., E. Waters, D. Yach, D. McQueen, A. De Francisco, T. Stewart, P. Reddy, A. M. Gul- mezoglu, G. Galea, and A. Portela. 2005. Global priority setting for Cochrane systematic reviews of health promotion and public health research. Journal of Epidemiology and Community Health 59:193-197.
102. HHS (Department of Health and Human Services). 2000. Healthy People 2010: Understanding and improving health. Place Published: U.S. Government Printing Office. http://purl. access.gpo.gov/GPO/LPS4217 (accessed April 3, 2009).
103. Kung, H.-C., D. L. Hoyert, J. Xu, S. L. Murphy, and Division of Vital Statistics. 2008. Deaths: Final data for 2005. National vital statistics re-ports National Center for Health Statistics.
104. NPP (National Priorities Partnership). 2008. National priorities and goals. Washington, DC: National Quality Forum.
105. U.S. Cancer Statistics Working Group. 2009. United States cancer statistics: 1999-2005 Incidence and mortality web-based report. Atlanta: Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute.
106. Wennberg, J. E. 2009 (unpublished). Recommendations to the Institute of Medicine on comparative effectiveness research priorities. Submitted in response to a request from the Institute of Medicine Committee on Comparative Effectiveness Research Prioritization. The Dartmouth Institute for Health Policy and Clinical Practice.
107. Whitlock, E. P., S. A. Lopez, S. Chang, M. Helfand, M. Eder, and N. Floyd. 2009. Identifying, selecting, and refining topics for comparative effectiveness systematic reviews: AHRQ and the Effective Health Care Program. http://effectivehealthcare.ahrq.gov/repFiles/ 20090427IdenttifyingTopics.pdf (accessed June 5, 2009).
108. Academy of Medical Sciences. 2006. Personal data for public good: Using health information in medical research. http://www.acmedsci.ac.uk/images/project/Personal.pdf(accessed August 28, 2008).
109. Andejeski, Y., I. T. Bisceglio, K. Dickersin, J. E. Johnson, S. I. Robinson, H. S. Smith, F. M. Visco, and I. M. Rich. 2002a. Quantitative impact of including consumers in the scientific review of breast cancer research proposals. Journal of Women's Health & Gender-Based Medicine 11(4):379-388.
110. Andejeski, Y., E. S. Breslau, E. Hart, N. Lythcott, L. Alexander, I. Rich, I. Bisceglio, H. S. Smith, and F. M. Visco. 2002b. Benefits and drawbacks of including consumer reviewers in the scientific merit review of breast cancer research. Journal of Women's Health & Gender-Based Medicine 11(2):119-136.
111. Aryal, K. R., and H. Al-khaffaf. 2006. Venous thromboembolic complications following air travel: What's the quantitative risk? A literature review. European Journal of Vascular and Endovascular Surgery 31(2):187-199.
112. Bell, C. L., J. Davis, R. C. Harrigan, E. Somogyi-Zalud, M. K. G. Tanabe, and K. H. Masaki. 2009. Factors associated with place of death for elderly Japanese American men: The Honolulu heart program and Honolulu-Asia aging study. Journal of the American Geriatrics Society 57(4):714-718.
113. Berry, D. A. 2003. Statistical innovations in cancer research. In Cancer Medicine 6th Edition, Edited by J. Holland, E. Frei, D. W. Kufe, R. E. Pollock, R. R. Weichselbaum, R. C. Bast and T. S. Gansler. Hamilton: BC Decker. Pp. 465-478.
114. Braunstein, J. B., N. S. Sherber, S. P. Schulman, E. L. Ding, and N. R. Powe. 2008. Race, medical researcher distrust, perceived harm, and willingness to participate in cardiovascular prevention trials. Medicine 87(1):1-9.
115. Brown, D. R., M. N. Fouad, K. Basen-Engquist, and G. Tortolero-LUna. 2000. Recruitment and retention of minority women in cancer screening, prevention and treatment trials. Annals of Epidemiology 10:S13-S21.
116. Brown, J., J. Holmes, J. Maro, B. Syat, K. Lane, R. Lazarus, and R. Platt. 2009. Developing a distributed research network and cooperative to conduct population-based studies and safety surveillance. In Report 1: Design Specifications for Network Prototype and Research Cooperative.
117. Chan, A. W., A. Hrobjartsson, M. T. Haahr, P. C. G0tzsche, and D. G. Altman. 2004. Empirical evidence for selective reporting of outcomes in randomized trials: Comparison of protocols to published articles. JAMA 291:2457-2465.
118. Chou, R., and M. Helfand. 2005. Challenges in systematic reviews that assess treatment harms. Annals of Internal Medicine 142(12 [Part 2]):1090-1099.
119. CMS (Centers for Medicare & Medicaid). 2009. Prescription drug coverage general information: Overview. http://www.cms.hhs.gov/PrescriptionDrugCovGenIn/ (accessed May 9, 2009).
120. Cupples, L., R. D'Agostino, and D. Kiely. 1988. The Framingham heart study. Section 35. An Epidemiological Investigation of Cardiovascular Disease Survival Following Cardiovascular Events: 30 Year Follow-up.
121. Cystic Fibrosis Foundation. 2009. Patient registry report. http://www.cff.org/treatments/Care-CenterNetwork/PatientRegistryReport/ (accessed June 16, 2009).
122. de Simone, G., R. B. Devereux, M. Chinali, M. J. Roman, E. T. Lee, H. E. Resnick, and B. V. Howard. 2009. Metabolic syndrome and left ventricular hypertrophy in the prediction of cardiovascular events: The strong heart study. Nutrition, Metabolism and Cardiovascular Diseases 19(2):98-104.
123. Deber, R. B., N. Kraetschmer, and J. Irvine. 1996. What role do patients wish to play in treatment decision making. Archives of Internal Medicine 156:1414-1420.
124. Degner, L. F., and C. A. Russell. 1988. Preferences for treatment control among adults with cancer. Research in Nursing & Health 11:367-374.
125. Dickersin, K. 2005. Publication bias: Recognizing the problem, understanding its origins and scope, and preventing harm. In Publication Bias in Meta-analysis: Prevention, Assessment, and Adjustments, Edited by H. Rothstein, A. Sutton and M. Borenstein. London, UK: John Wiley and Sons, Ltd.
126. Dickersin, K., and Y.-I. Min. 1993. Publication bias: The problem that won't go away. In Doing More Good than Harm: The Evaluation of Health Care Interventions. Edited by K.S. Warren and F. Mosteller. New York Academy of Sciences. 135-148.
127. Dougherty, D., and P. H. Conway. 2008. The "3T's" road may transform US health care: The "how" of high-quality care. JAMA 299(19):2319-2321.
128. Entwistle, V. A., M. J. Renfrew, S. Yearley, J. Forrester, and T. Lamont. 1998. Lay perspectives: Advantages for health research. BMJ 316:463-366.
129. Faridi, Z., J. Grunbaum, B. S. Gray, A. Franks, and E. Simoes. 2007. Community-based participatory research: Necessary next steps. Pre-venting Chronic Disease: Public Health Research, Practice and Policy 4(3):1-5.
130. Farmer, D., S. A. Jackson, F. Camacho, and M. A. Hall. 2007. Attitudes of African American and low socioeconomic status White women toward medical research. Journal of Health Care for the Poor and Underserved 18:85-99.
131. FDA (Food and Drug Administration). 2008. FDA's Sentinel Initiative. http://www.fda.gov/oc/initiatives/advance/sentinel/ (accessed May 5, 2009).
132. FDA 2009. Information for patient advocates http://www.fda.gov/oashi/home.html (accessed May 13, 2009).
133. Ford, E. W., N. Menachemi, L. T. Peterson, and T. R. Huerta. 2009. Resistance is futile: But it is slowing the pace of EHR adoption nonetheless. Journal of the American Medical Informatics Association 16(3):274-281.
134. Fretheim, A., H. J. Schanemann, and A. D. Oxman. 2006. Improving the use of research evidence in guideline development: 3. Group composition and consultation process. Health Research Policy and Systems 4.
135. Fung, M. M., R. Bettencourt, and E. Barrett-Connor. 2004. Heart disease risk factors predict erectile dysfunction 25 years later: The rancho bernardo study. Journal of the American College of Cardiology 43(8):1405-1411.
136. Furberg, C. D., J. T. Wright Jr, B. R. Davis, J. A. Cutler, M. Alderman, H. Black, W. Cushman, R. Grimm, L. J. Haywood, F. Leenen, S. Oparil, J. Probstfield, P. Whelton, C. Nwachuku, D. Gordon, M. Proschan, P. Einhom, C. E. Ford, L. B. Piller, I. K. Dunn, D. Goff, S. Pressel, J. Bettencourt, B. DeLeon, L. M. Simpson, J. Blanton, T. Geraci, S. M. Walsh, C. Nelson, M. Rahman, A. Juratovac, R. Pospisil, L. Carroll, S. Sullivan, J. Russo, G. Barone, R. Christian, S. Feldman, T. Lucente, D. Calhoun, K. Jenkins, P. McDowell, J. Johnson, C. Kingry, J. Alzate, K. L. Margolis, L. A. Holland-Klemme, B. Jaeger, J. Williamson, G. Louis, P. Ragusa, A. Williard, R. L. S. Ferguson, J. Tanner, J. Eckfeldt, R. Crow, and J. Pelosi. 2002. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA 288(23):2981-2997.
137. Giuliano, A. R., N. Mokuau, C. Hughes, G. Tortelero-Luna, B. Risendal, R. C. S. Ho, T. E. Prewitt, and W. J. McCaskill-Stevens. 2000. Participation of minorities in cancer research: The influence of structural, cultural, and linguistic factors. Annals of Epidemiology 10:S22-S34.
138. Gliklich, R. E., and N. A. Dreyer. 2007. Registries for evaluating patient outcomes: A user's guide. Rockville, MD: Agency for Healthcare Research and Quality.
139. Godwin, M., L. Ruhland, I. Casson, S. MacDonald, D. Delva, R. Birtwhistle, M. Lam, and R. Seguin. 2003. Pragmatic controlled clinical trials in primary care: The struggle between external and internal validity. BMC Medical Research Methodology 3:1-7.
140. Guadagnoli, E., and P. Ward. 1998. Patient participation in decision-making. Social Science & Medicine 47(3):329-339.
141. Hanley, B., A. Truesdale, A. King, D. Elbourne, and I. Chalmers. 2001. Involving consumers in designing, conducting and interpreting randomised controlled trials: Questionnaire survey. BMJ 322:519-523.
142. The Henry J. Kaiser Foundation. 2009. Medicaid & CHIP, http://www.statehealthfacts.org/comparecat.jsp?cat=4 (accessed May 9, 2009).
143. Hubbard, G., L. Kidd, and E. Donaghy. 2008. Involving people affected by cancer in research: A review of literature. European Journal of Cancer Care 17(3):233-244.
144. INVOLVE. 2009. Promoting public involvement in NHS, public health and social care research. http://www.invo.org.uk/ (accessed May 13, 2009).
145. IOM (Institute of Medicine). 1997. A re-view of the Department of Defense's program for breast cancer research. Washington, DC: National Academy Press.
146. IOM 2001. Crossing the quality chasm: A new health system for the 21st century, National Academy Press. http://www.nap.edu/catalog/10027.html (accessed April 20, 2009).
147. IOM 2002. Responsible research: A systems approach to protecting research participants. Washington, DC: The National Academies Press.
148. IOM 2007. Learning what works best: The nation's need for evidence on comparative effectiveness in health care. http://www.iom.edu/ebm-effectiveness (accessed April 15, 2009).
149. IOM 2008. Knowing what works in health care: A roadmap for the nation. Edited by J. Eden, B. Wheatley, B. J. McNeil and H. Sox. Washington, DC: The National Academies Press.
150. IOM 2009a. Beyond the HIPAA privacy rule: Enhancing privacy, improving health through research. Edited by Nass, S. J., L. A. Levit and L. O. Gostin. Washington, DC: The National Academies Press.
151. IOM 2009b. Conflict of interest in medical research, education, and practice. Edited by B. Lo, and M. J. Field. Washington, DC: The National Academies Press.
152. IOM 2009c. A framework for the workforce required for comparative effectiveness research. In Learning What Works Infrastructure Required to Learn Which Care is Best (in press). Washington, DC: The National Academies Press.
153. Johnson, B., M. Abraham, J. Conway, L. Simmons, S. Edgman-Levitan, P. Sodomka, J. Schlucter, and D. Ford. 2008. Partnering with patients and families to design a patient- and family-centered health care system: Recommendations and promising practices. http://www.ihi.org/NR/rdonlyres/C810CCBB-2DEB-4678-994A-57D9B703F98D/0ZPartneringwithPatientsandFamiliesRecommendationsApr08.pdf (accessed June 12, 2009).
154. Jones, L., and K. Wells. 2007. Strategies for academic and clinician engagement in community- participatory partnered research. JAMA 297(4):407-410.
155. Kent, D. M., and R. A. Hayward. 2007. Limitations of applying summary results of clinical trials to individual patients. JAMA 298:1209-1212.
156. Lindenmeyer, A., H. Hearnshaw, J. Sturt, R. Ormerod, and G. Altchison. 2007. Assessment of the benefits of user involvement in health research from the Warwick Diabetes Care Research User Group: A qualitative case study. Health Expectations 10:268-277.
157. Mansell, D., R. M. Poses, L. Kazis, and C. A. Duefield. 2000. Clinical factors that influence patients' desire for participation in decisions about illness. Archives of Internal Medicine 160:2991-2996.
158. Mattews, S. C. 2009. Physician autonomy and informed decision making: Finding the balance for patient safety and quality. JAMA 300(24):2913-2915.
159. Mazur, D. J., and D. H. Hickam. 1997. Patients' preferences for risk disclosure and role in decision making for invasive medical procedures. Journal of General Internal Medicine 12:114-117.
160. McClellan, M., and J. Benner. 2009. Comparative effectiveness research: Will it bend the health care cost curve and improve quality? In Implementing Comparative Effectiveness Research: Priorities, Methods, and Impact. Washington, DC: Brookings.
161. Meier, B. 2009. New effort reopens a medical minefield The New York Times, B1.
162. Merlini, L., P. Kishnani, B. Byrne, W. Maller-Felber, L. Case, and A. D. Ploeg. 2008. The Pompe registry: Centralized data collection to track the natural course of Pompe disease. Clinical Therapeutics 30(SUPPL. 1).
163. Minkler, M., A. G. Blackwell, M. Thompson, and H. Tamir. 2003. Community-based participatory research: Implications for public health funding. American Journal of Public Health 93(8):1210-1213.
164. National Center for Research Resources. 2009. Clinical and translational science awards. http://www.ncrr.nih.gov/clinical_research_resources/clinical_and_translational_science:awards/ (accessed June 16, 2009).
165. National Heart, Lung, and Blood Institute. 2009. Women's health initiative: Observational fact sheet. http://www.nhlbi.nih.gov/whi/os.htm (accessed May 23, 2009).
166. NIH (National Institutes of Health). 2009. NIH roadmap for medical research. http://nihroad- map.nih.gov/ (accessed June 16, 2009).
167. Office of National Coordinator for Health Information Technology. 2009. Information related to the Economic Recovery Act of 2009. www.HealthIT.hhs.gov (accessed May 11, 2009).
168. Oliver, S. R., R. W. Rees, L. Clarke-Jones, R. Milne, A. R. Oakley, J. Gabbay, K. Stein, P. Buchanan, and G. Gyte. 2008. A multidimensional conceptual framework for analysing public involvement in health services research. Health Expectations 11:72-84.
169. Omenn, G. S. 1999. Caring for the community: The role of partnerships. Academic Medicine 74(7):782-789.
170. Peterson, E., and C. W Yancy. 2009. Eliminating racial and ethnic disparities in cardiac care. New England Journal of Medicine 360(12):1172-1174.
171. President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research. 1982. Making health care decisions: The ethical and legal implications of informed consent in the patient-provider relationship. http://bioethics.gov/ reports/past_commissions/making_health_care_decisions.pdf (accessed June 25, 2009).
172. Rawlins, M. 2008. De testimonio: On the evidence for decisions about the use of therapeutic interventions. The Lancet 372(9656):2152-2161.
173. Rising, K., P. Bacchetti, and L. Bero. 2008. Reporting bias in drug trials submitted to the food and drug administration: Review of publication and presentation. Public Library of Science Medicine 5(11):e217.
174. Sabin, J. E., K. Mazor, V. Meterko, S. L. Goff, and R. Platt. 2008. Comparing drug effectiveness at health plans: The ethics of cluster randomized trials. Hastings Center Report 38(5):39-48.
175. Saunders, C., A. Girgis, P. Butow, S. Crossing, and A. Penman. 2008. From inclusion to independence-Training consumers to review research. Health Research Policy and Systems 6(3).
176. Schwartz, R. S., G. D. Curfman, S. Morrissey, and J. M. Drazen. 2008. Full disclosure and the funding of biomedical research. New England Journal of Medicine 358(17):1850-1851.
177. Shojania, K. G., and J. M. Grimshaw. 2005. Evidence-based quality improvement: The state of the science. Health Affairs 24(1):138-150.
178. Staniszewska, S., N. Jones, M. Newburn, and S. Marshall. 2007. User involvement in the development of a research bid: Barriers, enablers and impacts. Health Expectations 10:173-183.
179. Tatsioni, A., D. A. Zarin, N. Aronson, D. J. Samson, C. R. Flamm, C. Schmid, and J. Lau. 2005. Challenges in systematic reviews of diagnostic technologies. Annals of Internal Medicine 142(12 Part 2):1048-1055.
180. Teva Pharmaceuticals. 2008. Teva clozapine patient registry. https://clozapineregistry.com/ AboutRegistry/GeneralOverview.aspx (accessed June 16, 2009).
181. Tunis, S. 2009. Strategies to improve comparative effectiveness research methods and data infrastructure. In Implementing Comparative Effectiveness Research: Priorities, Methods, and Impact. Washington, DC: Brookings.
182. Turner, E. H., A. M. Matthews, E. Linardatos, R. A. Tell, and R. Rosenthal. 2008. Selective publication of antidepressant trials and its influence on apparent efficacy. New England Journal of Medicine 358(3):252-260.
183. United States Cochrane Center Consumers United for Evidence-based Healthcare. 2009. Understanding evidence-based healthcare: A foundation for action. http://apps1.jhsph. edu/cochrane/CUEwebcourse.htm (accessed May 23, 2009).
184. Van Spall, H. G. C., A. Toren, A. Kiss, and R. A. Fowler. 2007. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: A systematic sampling review. JAMA 297(11):1233-1240.
185. Weinfurt, K. P., D. M. Seils, J. P. Tzeng, L. Lin, K. A. Schulman, and R. M. Califf. 2008. Consistency of financial interest disclosures in the biomedical literature: The case of coronary stents. PLoS ONE 3(5).
186. Weinstein, J. N., K. Clay, and T. S. Morgan. 2007. Informed patient choice: Patient-centered valuing of surgical risks and benefits. Health Affairs 26(3):726-730.
187. Wendler, D., R. Kington, J. Madans, G. Van Wye, H. Christ-Schmidt, L. A. Pratt, O. W. Brawley, C. P. Gross, and E. Emanuel. 2006. Are racial and ethnic minorities less willing to participate in health research? PLoS Medicine 3(2):201-210.
188. Wennberg, J. E., and E. S. Fisher. 2008. Tracking the care of patients with severe chronic illness: The Dartmouth Atlas of health care 2008. Dartmouth Institute for Health Policy and Clinical Practice, Center for Health Policy Research. http://www.dartmouthatlas.org/atlases/2008%5FChronic%5FCare%5FAtlas.pdf (accessed June 8, 2009).
189. Westfall, J. M., J. Mold, and L. P. Fagnan. 2007. Practice-based research-"Blue highways" on the NIH roadmap. JAMA 297:403-406.
190. Williams, I. C., and G. Corbie-Smith. 2006. Investigator beliefs and reported success in recruiting minority participants. Contemporary Clinical Trials 27:580-586.
191. Zerhouni, E. A. 2005. Translational and clinical science-Time for a new vision. New England Journal of Medicine 353(15):1621-1623.
192. AHRQ (Agency for Healthcare Research and Quality). 2009a. Medical Expenditure Panel Survey: Total expenses for conditions by site of service: United States http://www.meps.ahrq.gov/mepsweb/ (accessed March 10, 2009).
193. AHRQ 2009b. Total number of events accounting for expenditures by site of service: United States, 2006. In Medical Expenditure Panel Survey Component Data.
194. AHRQ 2009c. Total number of people accounting for expenditures (deduplicated) by site of service: United States, 2006. In Medical Expenditure Panel Survey Component Data.
195. Kung, H.-C., D. L. Hoyert, J. Xu, S. L. Murphy, and Division of Vital Statistics. 2008. Deaths: Final data for 2005. National Vital Statistics Re-ports National Center for Health Statistics.
196. Wennberg, J. E. 2009 (unpublished). Recommendations to the Institute of Medicine on comparative effectiveness research priorities. Submitted in response to a request from the Institute of Medicine Committee on Comparative Effectiveness Research Prioritization. The Dartmouth Institute for Health Policy and Clinical Practice.
197. AHRQ (Agency for Healthcare Research and Quality). 2009. Medical Expenditure Panel Survey. http://www.meps.ahrq.gov/mepsweb/ (accessed March 10, 2009).
198. Doyle, J., E. Waters, D. Yach, D. McQueen, A. De Francisco, T. Stewart, P. Reddy, A. M. Gul- mezoglu, G. Galea, and A. Portela. 2005. Global priority setting for Cochrane systematic reviews of health promotion and public health research. Journal of Epidemiology and Community Health 59:193-197.
199. HHS (Department of Health and Human Services). 2000. Healthy People 2010: Understanding and improving health. Place Published: U.S. Government Printing Office. http://purl. access.gpo.gov/GPO/LPS4217 (accessed April 3, 2009).
200. Kung, H.-C., D. L. Hoyert, J. Xu, S. L. Murphy, and Division of Vital Statistics. 2008. Deaths: Final data for 2005. National Vital Statistics Re-ports National Center for Health Statistics.
201. NIH (National Institutes of Health). 2009. Clinicaltrials.Gov. http://www.clinicaltrials.gov/ (accessed June 5, 2009).
202. NPP (National Priorities Partnership). 2008. National priorities and goals. Washington, DC: National Quality Forum.
203. Wennberg, J. E. 2009 (unpublished). Recommendations to the Institute of Medicine on comparative effectiveness research priorities. Submitted in response to a request from the Institute of Medicine Committee on Comparative Effectiveness Research Prioritization. The Dartmouth Institute for Health Policy and Clinical Practice.
204. Whitlock, E. P., S. A. Lopez, S. Chang, M. Helfand, M. Eder, and N. Floyd. 2009. Identifying, selecting, and refining topics for comparative effectiveness systematic reviews: AHRQ and the Effective Health Care Program. http://effectivehealthcare.ahrq.gov/repFiles/ 20090427IdenttifyingTopics.pdf (accessed June 5, 2009).